Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies

Figure 3

Proportion of patients with investigator-assessed symptoms in the week preceding the 6-month visit (pooled intention-to-treat population). Numbers (n) relate to patients without the individual symptom upon entering the 6-month maintenance phase. p = 0.02, ¥p = 0.002, p = 0.003, §p = 0.0001, ****p < 0.0001, all versus placebo.

Back to article page